You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Methotrexate (MTX)

Showing 1 - 25 of 1,699
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly-diagnosed PCNSL Treated WithMethotrexate and

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Oct 30, 2023

Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Paris, France
    Hôpital Pitié-Salpêtrière
Oct 24, 2022

Uncontrolled Gout, Chronic Gout Trial in United States (Pegloticase and Methotrexate (MTX))

Recruiting
  • Uncontrolled Gout
  • Chronic Gout
  • Pegloticase and Methotrexate (MTX)
  • Anchorage, Alaska
  • +11 more
Dec 9, 2022

Primary CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Methotrexate (MTX))

Recruiting
  • Primary Central Nervous System Lymphoma
  • Shanghai, Shanghai, China
    Department of Hematology, Huashan Hospital, Fudan University
Jul 26, 2022

Rheumatoid Arthritis Trial in China (Tocilizumab, MTX, Placebo Matched to MTX)

Completed
  • Rheumatoid Arthritis
  • Baotou, China
  • +19 more
Dec 5, 2022

Rheumatoid Arthritis Trial in Chi?inau (AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg)

Recruiting
  • Rheumatoid Arthritis
  • AP1189, 60 mg
  • +3 more
  • Chișinău, Moldova, Republic of
    Timofei Mosneaga Republican Clinical Hospital
Jan 5, 2023

Moderately to Severely Active Rheumatoid Arthritis Trial in Jiujiang (HLX01, Methotrexate(MTX))

Completed
  • Moderately to Severely Active Rheumatoid Arthritis
  • Jiujiang, Jiangxi, China
    Jiujiang No.1 peoples's hospital
May 4, 2022

Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

Completed
  • Moderate to Severe Active Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 14, 2023

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute Trial in Paris (Methotrexate, Placebo)

Recruiting
  • Allogeneic Disease
  • +3 more
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Oct 22, 2021

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

Primary CNS Lymphoma Trial in Hanzhou (Orelabrutinib, Rituximab, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022

Primary CNS Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Methotrexate)

Completed
  • Primary Central Nervous System Lymphoma
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 18, 2022

Rheumatoid Arthritis Trial (Natrunix with MTX (+folate), Natrunix with MTX (+folate))

Not yet recruiting
  • Rheumatoid Arthritis
  • Natrunix with MTX placebo (+folate)
  • Natrunix placebo with MTX (+folate)
  • (no location specified)
May 2, 2022

Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

Recruiting
  • Secondary Central Nervous System Lymphoma
  • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
May 25, 2022

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Moderate and Severe RheumatoId Arthritis Trial in Beijing (Placebo plus MTX, RC18 160 mg plus MTX)

Active, not recruiting
  • Moderate and Severe RheumatoId Arthritis
  • Placebo plus MTX
  • RC18 160 mg plus MTX
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 9, 2022

Psoriasis Trial in Aswan (Narrowband ultraviolet B, Methotrexate)

Active, not recruiting
  • Psoriasis
  • Aswan, Aswan Governorate, Egypt, Egypt
    Aswan University - Faculty of Medicine
Jun 16, 2022

Rheumatoid Arthritis, Autoimmune Diseases, Influenza Trial in Seongnam-si, Seoul (MTX-hold)

Completed
  • Rheumatoid Arthritis
  • +3 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +2 more
Dec 14, 2022

Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)

Completed
  • Rheumatoid Arthritis (RA)
  • Daegu, Korea, Republic of
  • +9 more
Aug 26, 2021

Rheumatoid Arthritis Trial in United States (ATI-450, Placebo oral tablet, Methotrexate)

Completed
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +4 more
Mar 24, 2021

Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Frankfurt am Main, Hessia, Germany
    CIRI
Mar 1, 2022

Rheumatoid Arthritis Trial in Worldwide (ABX464 50mg, Matching Placebo, ABX464 100mg)

Completed
Has Results
  • Rheumatoid Arthritis
  • ABX464 50mg
  • +3 more
  • Bruxelles, Belgium
  • +23 more
Feb 3, 2022

Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)

Recruiting
  • Arthritis, Rheumatoid
  • Jinan, Shandong, China
    Qilu Hospital
Nov 28, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022